In the week of March 2, 2026, 22 holders filed a new Schedule 13D and 81 a new Schedule 13G reporting 5% or more of a company. The largest stake reported that week is Toronto Dominion Investments LLC's 100% of Blackrock Munivest Fund, Inc. (Schedule 13D, March 6, 2026).
New 13D22
New 13G81
Stated intents0
The week of 2026-03-02, 22 holders filed a new Schedule 13D and 81 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-03-06 | Blackrock Munivest Fund, Inc. | Toronto Dominion Investments LLC | 100% | SCHEDULE 13D |
| 2026-03-06 | Blackrock Munivest Fund Ii, Inc. | Toronto Dominion Investments LLC | 100% | SCHEDULE 13D |
| 2026-03-02 | Indaptus Therapeutics, Inc. | Lazar David E. | 98% | SCHEDULE 13D |
| 2026-03-06 | Coincheck Group N.V. | Monex Group, Inc. | 83.16% | SCHEDULE 13D |
| 2026-03-03 | Nomadar Corp. | Sport City Cadiz S.L. | 66.27% | SCHEDULE 13D |
| 2026-03-02 | Intelligent Group Ltd | Hong Kong Maysunshine Investment Management Co., Limited | 29.3% | SCHEDULE 13D |
| 2026-03-02 | KORE Group Holdings, Inc. | Jay Grossman | 27.65% | SCHEDULE 13D |
| 2026-03-04 | Proem Acquisition Corp I | Proem SPAC Partners I LLC | 26.1% | SCHEDULE 13D |
| 2026-03-05 | Illumination Acquisition Corp. I | Illumination Acquisition 1 Sponsor LLC | 25.7% | SCHEDULE 13D |
| 2026-03-02 | TRG Latin America Acquisitions Corp. | TRG Latin America Acquisitions LLC | 23% | SCHEDULE 13D |
| 2026-03-03 | Eagle Nuclear Energy Corp. | Blue Bird Capital Enterprises LLC | 20.88% | SCHEDULE 13D |
| 2026-03-04 | Xponential Fitness, Inc. | Voss Capital, LP | 18.2% | SCHEDULE 13D |
| 2026-03-02 | Blackrock Muniyield Quality Fund, Inc. | JPMorgan Chase & Co. | 17.26% | SCHEDULE 13D |
| 2026-03-02 | Infinity Natural Resources, Inc. | Etineles Holdings V, LLC | 16.19% | SCHEDULE 13D |
| 2026-03-03 | Jaguar Uranium Corp. | IsoEnergy Ltd. | 16.1% | SCHEDULE 13D |
| 2026-03-04 | Par Technology Corporation | Voss Capital, LP | 13.2% | SCHEDULE 13D |
| 2026-03-05 | Sabre Corp | Constellation Software Inc | 12.7% | SCHEDULE 13D |
| 2026-03-03 | Ziff Davis Inc | Pale Fire Capital SE | 6.9% | SCHEDULE 13D |
| 2026-03-04 | Mega Matrix Inc | Cosmic Vision Innovations Ltd | 5.66% | SCHEDULE 13D |
| 2026-03-05 | Jingbo Technology, Inc. | Hangdu Technology Ltd | 5.28% | SCHEDULE 13D |
| 2026-03-04 | Korea Fund Inc | Saba Capital Management, L.P. | 5.13% | SCHEDULE 13D |
| 2026-03-05 | Yatra Online, Inc. | Altai Capital Management, L.P. | 5.1% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-03-06 | Advisors' Inner Circle Fund III | Brown Advisory Inc | 98.72% | SCHEDULE 13G |
| 2026-03-06 | First Trust Exchange-Traded Fund VI | First Trust Portfolios L.P. | 89.16% | SCHEDULE 13G |
| 2026-03-06 | First Trust Exchange-Traded Fund VI | First Trust Portfolios L.P. | 69.64% | SCHEDULE 13G |
| 2026-03-06 | Scage Future | Chao Gao | 62.9% | SCHEDULE 13G |
| 2026-03-06 | Obook Holdings, Inc. | Wang Chun Kai | 44.4% | SCHEDULE 13G |
| 2026-03-06 | Republic Power Group Ltd | Cetera Wealth Services, LLC | 37.83% | SCHEDULE 13G |
| 2026-03-02 | Intelligent Group Ltd | VL Prime Capital Limited | 29.3% | SCHEDULE 13G |
| 2026-03-04 | Innovator ETFs Trust | Brookstone Capital Management, LLC | 26.55% | SCHEDULE 13G |
| 2026-03-06 | Atlas Critical Minerals Corporation | Marc Fogassa | 24.47% | SCHEDULE 13G |
| 2026-03-05 | Star Gold Corp. | Myrmikan Gold Fund, LLC | 18.3% | SCHEDULE 13G |
| 2026-03-04 | Innovator ETFs Trust | Brookstone Capital Management, LLC | 15.13% | SCHEDULE 13G |
| 2026-03-06 | Westin Acquisition Corp. | Karpus Management, Inc. | 14.94% | SCHEDULE 13G |
| 2026-03-04 | 2023 ETF Series Trust | BlackRock Portfolio Management LLC | 13.6% | SCHEDULE 13G |
| 2026-03-06 | Avalo Therapeutics Inc | Fmr LLC | 11.5% | SCHEDULE 13G |
| 2026-03-06 | Obook Holdings, Inc. | Hsieh Chung Han | 11.5% | SCHEDULE 13G |
| 2026-03-04 | 2023 ETF Series Trust | BlackRock Portfolio Management LLC | 11.4% | SCHEDULE 13G |
| 2026-03-06 | Apogee Therapeutics, Inc. | T. Rowe Price Investment Management, Inc. | 11.3% | SCHEDULE 13G |
| 2026-03-06 | Nektar Therapeutics | Fmr LLC | 11.1% | SCHEDULE 13G |
| 2026-03-06 | GPGI, Inc. | Fmr LLC | 10.8% | SCHEDULE 13G |
| 2026-03-05 | IRulya Therapeutics Inc. | Group One Trading LLC | 10.7% | SCHEDULE 13G |
| 2026-03-06 | Kiniksa Pharmaceuticals International, plc | Fmr LLC | 10.6% | SCHEDULE 13G |
| 2026-03-05 | RingCentral Inc | Vanguard Portfolio Management | 10.57% | SCHEDULE 13G |
| 2026-03-06 | TechTarget, Inc. | Lynrock Lake LP | 10.4% | SCHEDULE 13G |
| 2026-03-04 | Gauzy Ltd | Hamilton Global Opportunities plc | 10.3% | SCHEDULE 13G |
| 2026-03-05 | Appian Corp | Vanguard Portfolio Management | 10.06% | SCHEDULE 13G |
| 2026-03-05 | Acadia Realty Trust | Vanguard Portfolio Management | 10.01% | SCHEDULE 13G |
| 2026-03-05 | Extreme Networks Inc | Vanguard Portfolio Management | 10% | SCHEDULE 13G |
| 2026-03-06 | Agomab Therapeutics NV | Fmr LLC | 10% | SCHEDULE 13G |
| 2026-03-02 | In8bio, Inc. | Lytton Laurence W | 9.99% | SCHEDULE 13G |
| 2026-03-06 | GalaxyEdge Acquisition Corp | Feis Equities LLC | 9.98% | SCHEDULE 13G |
| 2026-03-02 | Ideal Power Inc. | Lytton Laurence W | 9.9% | SCHEDULE 13G |
| 2026-03-04 | APEX Tech Acquisition Inc. | Feis Equities LLC | 8.93% | SCHEDULE 13G |
| 2026-03-02 | Seneca Bancorp, Inc. | Amended and Restated Seneca Savings Bank, National Association Employee Stock Ownership Plan Trust | 8.9% | SCHEDULE 13G |
| 2026-03-02 | Omada Health Inc | Divisadero Street Capital Management, LP | 8.7% | SCHEDULE 13G |
| 2026-03-02 | Solana Co | Kathmere Capital Management, LLC | 8.7% | SCHEDULE 13G |
| 2026-03-04 | Immunic, Inc. | Deep Track Capital, LP | 8.69% | SCHEDULE 13G |
| 2026-03-04 | Apartment Invt & Mgmt Co -A | Madison Avenue International LP | 8.6% | SCHEDULE 13G |
| 2026-03-06 | Draganfly Inc. | Kenneth Griffin | 8.6% | SCHEDULE 13G |
| 2026-03-06 | Ramaco Resources, Inc. | Dayah Capital LLC | 8.4% | SCHEDULE 13G |
| 2026-03-03 | Genesis Holdings Inc | Carpathia LLC | 8.3% | SCHEDULE 13G |
| 2026-03-06 | Hippo Holdings Inc | The Lennar Foundation, Inc. | 8% | SCHEDULE 13G |
| 2026-03-04 | Fortress Value Acquisition Corp. V | Alberta Investment Management Corp | 7.94% | SCHEDULE 13G |
| 2026-03-02 | Healthcare Triangle, Inc. | Orca Capital AG | 7.4% | SCHEDULE 13G |
| 2026-03-06 | TGE Value Creative Solutions Corp. | Morgan Stanley | 7.3% | SCHEDULE 13G |
| 2026-03-03 | Edesa Biotech, Inc. | Point72 Asset Management, L.P. | 7.2% | SCHEDULE 13G |
| 2026-03-06 | Rallybio Corp | Fmr LLC | 7.1% | SCHEDULE 13G |
| 2026-03-04 | APEX Tech Acquisition Inc. | Space Summit Capital LLC | 7% | SCHEDULE 13G |
| 2026-03-05 | Change Agents Corporation | Mitchell P. Kopin | 7% | SCHEDULE 13G |
| 2026-03-03 | Bicycle Therapeutics plc | Raymond Debbane | 6.3% | SCHEDULE 13G |
| 2026-03-06 | H2o America | Future Fund Board of Guardians | 6.2% | SCHEDULE 13G |
| 2026-03-05 | TRG Latin America Acquisitions Corp. | Sculptor Capital LP | 6.18% | SCHEDULE 13G |
| 2026-03-06 | Trinity Biotech plc | Novus Diagnostics Ltd. | 5.99% | SCHEDULE 13G |
| 2026-03-05 | APEX Tech Acquisition Inc. | Harraden Circle Investments, LLC | 5.96% | SCHEDULE 13G |
| 2026-03-04 | Averin Capital Acquisition Corp. | Sculptor Capital LP | 5.95% | SCHEDULE 13G |
| 2026-03-06 | Cars.com Inc | Pale Fire Capital SICAV a.s. | 5.9% | SCHEDULE 13G |
| 2026-03-02 | Atomera Inc | CVI Investments, Inc. | 5.8% | SCHEDULE 13G |
| 2026-03-04 | Protalix BioTherapeutics, Inc. | MAK Capital Fund LP | 5.8% | SCHEDULE 13G |
| 2026-03-05 | Cracker Barrel Old Country Store, Inc. | Millennium Management LLC | 5.8% | SCHEDULE 13G |
| 2026-03-06 | Hut 8 Corp. | Lone Pine Capital LLC | 5.6% | SCHEDULE 13G |
| 2026-03-06 | Tempus AI, Inc. | ARK Investment Management LLC | 5.44% | SCHEDULE 13G |
| 2026-03-03 | MOZAYYX Acquisition Corp. | MMCAP International Inc. SPC | 5.4% | SCHEDULE 13G |
| 2026-03-05 | Pelican Acquisition Corp | Merus Global Investments, LLC | 5.3% | SCHEDULE 13G |
| 2026-03-05 | ICL Group Ltd. | Harel Insurance Investments & Financial Services Ltd | 5.3% | SCHEDULE 13G |
| 2026-03-04 | CytomX Therapeutics, Inc. | Kynam Capital Management, LP | 5.29% | SCHEDULE 13G |
| 2026-03-04 | Cullinan Therapeutics, Inc. | Kynam Capital Management, LP | 5.27% | SCHEDULE 13G |
| 2026-03-02 | Gossamer Bio, Inc. | 683 Capital Management, LLC | 5.23% | SCHEDULE 13G |
| 2026-03-02 | Talkspace, Inc. | MAK Capital Fund LP | 5.2% | SCHEDULE 13G |
| 2026-03-02 | Paloma Acquisition Corp I | Linden Advisors LP | 5.2% | SCHEDULE 13G |
| 2026-03-03 | Geron Corporation | Soleus Capital Master Fund, L.P. | 5.2% | SCHEDULE 13G |
| 2026-03-03 | ClearThink 1 Acquisition Corp. | Harraden Circle Investments, LLC | 5.15% | SCHEDULE 13G |
| 2026-03-02 | Protara Therapeutics, Inc. | Millennium Management LLC | 5.1% | SCHEDULE 13G |
| 2026-03-03 | Haemonetics Corp | North Peak Capital Management, LLC | 5.1% | SCHEDULE 13G |
| 2026-03-03 | Zentalis Pharmaceuticals Inc | Squadron Master Fund LP | 5.1% | SCHEDULE 13G |
| 2026-03-04 | Luckin Coffee Inc. | First Beijing Investment Ltd | 5.1% | SCHEDULE 13G |
| 2026-03-06 | SunocoCorp LLC | Harvest Fund Advisors LLC | 5.1% | SCHEDULE 13G |
| 2026-03-05 | Star Holdings | The TCW Group, Inc., on behalf of the TCW Business Unit | 5.08% | SCHEDULE 13G |
| 2026-03-05 | OneIM Acquisition Corp. | Sculptor Capital LP | 5.05% | SCHEDULE 13G |
| 2026-03-03 | 1RT Acquisition Corp. | RP Investment Advisors LP | 5% | SCHEDULE 13G |
| 2026-03-03 | Climb Global Solutions, Inc. | AltraVue Capital, LLC | 5% | SCHEDULE 13G |
| 2026-03-05 | Gildan Activewear Inc | Caisse de d??p??t et placement du Qu??bec | 5% | SCHEDULE 13G |
| 2026-03-05 | Ormat Technologies Inc | Harel Insurance Investments & Financial Services Ltd | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Download this data (CSV)103 rows, with sources. Free with an account.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.